Article

Less demanding famciclovir regimen compares with acyclovir

Galveston, TX-Three-times-a-day treatment with famciclovir (Famvir, Novartis) was as effective against ophthalmic herpes zoster as five-times-a-day acyclovir (Zovirax, Glaxo Wellcome) in a major international trial, said Stephen K. Tyring, MD, PhD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
Related Content
(Image credit: AdobeStock/InkInvent) FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
August 15th 2025

FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy

3 Things You Should Know About the GA Pipeline
August 15th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 15th 2025

Robotic precision: Elevating the state of laser cataract surgery

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 15th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/NicoElNino) Dialing in precision: Astigmatism management with arcuate incisions
August 15th 2025

Dialing in precision: Astigmatism management with arcuate incisions

(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 15th 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

© 2025 MJH Life Sciences

All rights reserved.